Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
1 additional grant classified as “Other” (multi-disciplinary, infrastructure, etc.).
Funding by Fiscal Year
NIH fiscal year (Oct–Sep)
$7.7M
FY22
$10.5M
FY23
$11.4M
FY24
$9.9M
FY25
$12.6M
FY26
By Funding Mechanism
R01
19
R21
5
R37
4
F31
3
K99
3
U01
3
Funding Gap Analysis
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Ewing Sarcoma. Strongest funded area: Basic Science. Largest gap: Epidemiology / Natural History.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
241 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for Ewing sarcoma. Existing research activity suggests this may be a viable area for grant applications.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
40 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for Ewing sarcoma. Existing research activity suggests this may be a viable area for grant applications.
Adjacent Research(5 grants)
These grants mention Ewing Sarcoma as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Other(5)
OtherUM1Active
Targeting transcriptional addiction in fusion-driven sarcoma
McFadden, David et al.·UT SOUTHWESTERN MEDICAL CENTER·DALLAS, TX
